Why Larry Kramer's Galvinizing Message About LGBT Activism Is The Same As It's Always Been

“I still have that anger and I would still like to galvanize everyone, but it doesn’t appear that we’re galvanize-able as a population,” AIDS activist, author and playwright Larry Kramer said, discussing why LGBT activism is so necessary at a time in which he fears complacency has set in. That anger is on full display in the new documentary about his life and work as an activist and writer, “Larry Kramer in Love and Anger,” which debuts on HBO tonight at 9 p.m. “[It’s] too bad,” he continued, in an interview with me on SiriusXM Progress, referring to the the vital work ahead for activists on AIDS and LGBT rights,“because we need activism more than ever now.” That message – “we need activism more than ever now” -- is actually the message Kramer, who turned 80 last week, has been pressing, sometimes literally screaming it from the top of his lungs, for more than 30 years. And as a founder of Gay Mens Health Crisis and organizer within ACT UP, he’s saved countless lives with that anger. The film not only captures many of those moments, but charts a childhood, adolescence and young adulthood marred by homophobia and which helped infuse the anger and rebelliousness. The film, receiving some terrific reviews, was made by longtime filmmaker and activist Jean Carlomusto, a friend of Kramer’s who appears in the film at his bedside while he was in dire condition in an intensive care unit i...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news

Related Links:

CONCLUSIONS: Thanks to a growing global network of GPP practitioners and a burgeoning GPP Community of Practice, there has been substantive progress in making GPP an integral component of clinical HIV prevention research. The Wits RHI experience highlights the possibilities and the challenges to translating the GPP principles into concrete practices within specific clinical trials and across a research institute. Realizing the full potential of GPP, including direct and indirect - 'collateral benefits' will require the collective buy-in and support from sponsors, implementers and community stakeholders across the research ...
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
CONCLUSIONS: HIV prevention is situated at the intersection of unprecedented opportunity and crisis. Person-centred approaches to HIV prevention and research shift power dynamics, and have the potential to ensure a more sustainable response with each individual actively participating in their own care and meaningfully contributing to the production of knowledge on HIV prevention. This approach taps into the resourcefulness, resilience and knowledge of the person and their communities, to strengthen research and programmes, making them more relevant, appropriate and effective. PMID: 30334609 [PubMed - in process]
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
It is not just about "the trial": the critical role of effective engagement and participatory practices for moving the HIV research field forward. J Int AIDS Soc. 2018 Oct;21 Suppl 7:e25179 Authors: MacQueen KM, Auerbach JD PMID: 30334608 [PubMed - in process]
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
CONCLUSIONS: As evidence-informed engagement strategies emerge, these should inform the ethics submission and review process. Both parties in the review process should strive to avoid a superficial, check-list type approach that caricatures what should be a thorough, nuanced ethics review of a rich, responsive engagement process. PMID: 30334604 [PubMed - in process]
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
CONCLUSIONS: Brief, targeted surveys of trial sites to characterize use of broad strategies, specific practices and some outcomes are a feasible option for evaluating good participatory practice. Additional testing is warranted to assess and enhance validity, reliability and predictive value of indicators. Options for collecting outcome measures through additional objective means should be explored. PMID: 30334601 [PubMed - in process]
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
Authors: Wheeler DP, Lucas J, Wilton L, Nelson LE, Hucks-Ortiz C, Watson CC, Hutchinson C, Mayer KH, Kuo I, Magnus M, Beauchamp G, Shoptaw S, Emel LM, Chen YQ, Hightow-Weidman L, Fields SD PMID: 30334600 [PubMed - in process]
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
CONCLUSIONS: We advocate for the integration of qualitative with clinical and survey research methods in pragmatic clinical and community-level trials and implementation studies, and for increasing visibility of qualitative and mixed methods research in medical journals. Qualitative research from trials ideally should be published along with clinical outcome data, either integrated into the "main" trial papers or published concurrently in the same journal issue. Integration of qualitative research within trials can help not only to understand the why behind success or failure of interventions in different context...
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
CONCLUSIONS: These results suggest that having strong community social resources will reduce AGYW's risk of HIV acquisition. Work to mobilize communities, focusing on building social cohesion, shared concerns, critical consciousness, and effective and accountable leadership, can fortify prevention programming for AGYW. PMID: 30334377 [PubMed - in process]
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
CONCLUSIONS: Our findings identify important directions for future stakeholder engagement research and suggestions for policy. Most notably, we found that stakeholder engagement was more frequently conducted to inform early stages of HIV clinical trials compared to later stages. In order to meet recommendations established in the GPP guidelines, greater stakeholder engagement across all clinical trial stages is needed. PMID: 30334358 [PubMed - in process]
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
No abstract available
Source: The American Journal of Dermatopathology - Category: Pathology Tags: Clinical Pathologic Challenge Answer Source Type: research
More News: Health | HIV AIDS | Intensive Care | Liver | Liver Transplant | Lung Transplant | Men | Transplant Surgery | Transplants | Urology & Nephrology | Websites